Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.
Richardson PG, Perrot A, Mikhael J, Martin T, Beksac M, Spicka I, Capra M, D'Agostino M, Sonneveld P, Bisht K, Fukao T, Zhang R, Tada K, Tekle C, Macé S, Klippel Z, van de Velde H, Moreau P. Richardson PG, et al. Among authors: perrot a. Blood Cancer J. 2024 Nov 28;14(1):209. doi: 10.1038/s41408-024-01149-w. Blood Cancer J. 2024. PMID: 39609425 Clinical Trial.
Teclistamab in relapsed refractory multiple myeloma: a multi-institutional real-world study from the French early access program.
Perrot A, Hulin C, Boumendil A, Manjra H, Leveque A, Croizier C, Dony A, Mohty M, Roussel M, Manier S, Orsini-Piocelle F, Bauschert L, Bobin A, Frenzel L, Vincent L, Breal C, Eveillard JR, Gerome T, Tiab M, Chalayer E, Belkhir R, Mariette C, Moyer P, Chalopin T, Cherel B, Montes L, Coste A, Tabrizi R, Karlin L, Robu D, Huguet A, Harel S, Moreau P. Perrot A, et al. Haematologica. 2024 Nov 21. doi: 10.3324/haematol.2024.286118. Online ahead of print. Haematologica. 2024. PMID: 39568438 Free article.
Ixazomib, pomalidomide and dexamethasone in relapsed or refractory multiple myeloma characterized with high-risk cytogenetics: the IFM 2014-01 study.
Bobin A, Manier S, De Keizer J, Srimani JK, Hulin C, Karlin L, Caillot D, Lafon I, Mariette C, Araujo C, Arnulf B, Bareau B, Belhadj K, Benboubker L, Braun T, Calmettes C, Decaux O, Dib M, Demarquette H, Jacquet C, Sonntag C, Godet S, Jaccard A, Lenain P, Macro M, Richez-Olivier V, Tiab M, Vincent L, Zerazhi H, Pétillon MO, Rollet S, Gardeney H, Durand G, Levy A, Touzeau C, Perrot A, Moreau P, Facon T, Corre J, Ragot S, Avet-Loiseau H, Leleu X. Bobin A, et al. Among authors: perrot a. Haematologica. 2024 Nov 14. doi: 10.3324/haematol.2024.285916. Online ahead of print. Haematologica. 2024. PMID: 39540213 Free article.
Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort.
Chalopin T, Macro M, Decaux O, Royer B, Gounot R, Bobin A, Karlin L, Mohty M, Frenzel L, Perrot A, Manier S, Vincent L, Dib M, Slama B, Richez V, Allangba O, Zunic P, Newinger-Porte M, Mariette C, Joly B, Gay J, Botoc I, Malfuson JV, Garlantezec R, Hulin C. Chalopin T, et al. Among authors: perrot a. Clin Lymphoma Myeloma Leuk. 2024 Sep 30:S2152-2650(24)02350-4. doi: 10.1016/j.clml.2024.09.006. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39462749
Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study.
van de Donk NWCJ, Bahlis N, Costa LJ, Mateos MV, Nooka AK, Perrot A, Garfall AL, Thaman P, Qi K, Uhlar C, Chastain K, Doyle M, Usmani SZ. van de Donk NWCJ, et al. Among authors: perrot a. Blood Cancer J. 2024 Oct 21;14(1):186. doi: 10.1038/s41408-024-01160-1. Blood Cancer J. 2024. PMID: 39433732 Free PMC article. No abstract available.
[Update of guidelines of the AFSOS, SFRO, SFH, SFNCM, SFCE, GFRP for the management of radio-induced nausea and vomiting].
Faivre JC, Demoor-Goldschmitt C, Beddok A, Schmitt A, Malgras A, Quilliot D, Fabre J, Perrot A, Jovenin N, Dupin C, Pointreau Y, Scotté F, Bensadoun RJ, Charzat V, Thariat J. Faivre JC, et al. Among authors: perrot a. Bull Cancer. 2024 Nov;111(11):1065-1076. doi: 10.1016/j.bulcan.2024.08.015. Epub 2024 Oct 9. Bull Cancer. 2024. PMID: 39384523 Free article. French.
LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma - 2-year follow-up (final analysis).
Mateos MV, Weisel K, De Stefano V, Goldschmidt H, Delforge M, Mohty M, Dytfeld D, Angelucci E, Vincent L, Perrot A, Benjamin R, van de Donk NWCJ, Ocio EM, Roccia T, Schecter JM, Koskinen S, Haddad I, Strulev V, Mitchell L, Buyze J, Filho OC, Einsele H, Moreau P. Mateos MV, et al. Among authors: perrot a. Leukemia. 2024 Dec;38(12):2554-2560. doi: 10.1038/s41375-024-02404-6. Epub 2024 Sep 25. Leukemia. 2024. PMID: 39322709 Free PMC article.
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma.
Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, van de Donk NWCJ, Katodritou E, Schjesvold F, Balari AS, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A, Einsele H, Spencer A, Hajek R, Jurczyszyn A, Lonergan S, Ahmadi T, Liu Y, Wang J, Vieyra D, van Brummelen EMJ, Vanquickelberghe V, Sitthi-Amorn A, de Boer CJ, Carson R, Rodriguez-Otero P, Bladé J, Moreau P. Sonneveld P, et al. Among authors: perrot a. Future Oncol. 2024 Sep 17:1-21. doi: 10.1080/14796694.2024.2394323. Online ahead of print. Future Oncol. 2024. PMID: 39287147
Teclistamab for relapsed refractory multiple myeloma patients on dialysis.
Lebreton P, Lachenal F, Bouillie S, Pica GM, Aftisse H, Pascal L, Montes L, Macro M, Johnson N, Harel S, Fernandez M, De Renzis B, Lioure B, Lazareth A, Javelot M, Louni C, Huart A, Perrot A. Lebreton P, et al. Among authors: perrot a. Br J Haematol. 2024 Nov;205(5):2077-2079. doi: 10.1111/bjh.19772. Epub 2024 Sep 14. Br J Haematol. 2024. PMID: 39275880 No abstract available.
339 results